Prospera Financial Services Inc Grows Stock Holdings in UnitedHealth Group Incorporated (NYSE:UNH)

by · The Cerbat Gem

Prospera Financial Services Inc increased its stake in shares of UnitedHealth Group Incorporated (NYSE:UNH – Free Report) by 2.2% in the 3rd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 18,926 shares of the healthcare conglomerate’s stock after purchasing an additional 399 shares during the quarter. Prospera Financial Services Inc’s holdings in UnitedHealth Group were worth $11,074,000 as of its most recent SEC filing.

Other hedge funds also recently made changes to their positions in the company. Kathleen S. Wright Associates Inc. acquired a new position in shares of UnitedHealth Group during the 3rd quarter worth $27,000. Global Wealth Strategies & Associates grew its position in UnitedHealth Group by 152.4% during the third quarter. Global Wealth Strategies & Associates now owns 53 shares of the healthcare conglomerate’s stock worth $31,000 after buying an additional 32 shares during the period. Macroview Investment Management LLC lifted its position in shares of UnitedHealth Group by 671.4% during the 2nd quarter. Macroview Investment Management LLC now owns 54 shares of the healthcare conglomerate’s stock valued at $28,000 after acquiring an additional 47 shares during the period. West Financial Advisors LLC purchased a new position in UnitedHealth Group in the 3rd quarter valued at approximately $32,000. Finally, Bbjs Financial Advisors LLC acquired a new stake in UnitedHealth Group in the second quarter valued at $31,000. Institutional investors and hedge funds own 87.86% of the company’s stock.

UnitedHealth Group Stock Performance

Shares of NYSE UNH opened at $589.65 on Tuesday. The stock has a 50 day simple moving average of $582.75 and a 200-day simple moving average of $550.66. The company has a current ratio of 0.91, a quick ratio of 0.91 and a debt-to-equity ratio of 0.74. The company has a market cap of $542.64 billion, a PE ratio of 38.41, a P/E/G ratio of 1.74 and a beta of 0.58. UnitedHealth Group Incorporated has a 12-month low of $436.38 and a 12-month high of $630.73.

UnitedHealth Group (NYSE:UNH – Get Free Report) last released its earnings results on Tuesday, October 15th. The healthcare conglomerate reported $7.15 EPS for the quarter, beating the consensus estimate of $7.00 by $0.15. UnitedHealth Group had a net margin of 3.63% and a return on equity of 26.37%. The firm had revenue of $100.82 billion for the quarter, compared to analysts’ expectations of $99.14 billion. During the same quarter last year, the company earned $6.56 EPS. UnitedHealth Group’s quarterly revenue was up 9.2% on a year-over-year basis. On average, equities research analysts forecast that UnitedHealth Group Incorporated will post 27.6 EPS for the current year.

UnitedHealth Group Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Tuesday, December 17th. Stockholders of record on Monday, December 9th will be given a dividend of $2.10 per share. The ex-dividend date of this dividend is Monday, December 9th. This represents a $8.40 dividend on an annualized basis and a dividend yield of 1.42%. UnitedHealth Group’s dividend payout ratio (DPR) is presently 54.72%.

Analysts Set New Price Targets

A number of equities research analysts recently commented on UNH shares. Royal Bank of Canada lowered their price objective on shares of UnitedHealth Group from $615.00 to $595.00 and set an “outperform” rating on the stock in a research note on Wednesday, October 16th. Barclays dropped their price target on UnitedHealth Group from $604.00 to $603.00 and set an “overweight” rating for the company in a research report on Tuesday, October 22nd. Hsbc Global Res cut UnitedHealth Group from a “strong-buy” rating to a “hold” rating in a research report on Thursday, October 17th. Truist Financial reaffirmed a “buy” rating and set a $625.00 price target (down from $640.00) on shares of UnitedHealth Group in a research note on Wednesday, October 16th. Finally, TD Cowen upped their price objective on shares of UnitedHealth Group from $601.00 to $609.00 and gave the company a “buy” rating in a research note on Friday, October 18th. Three investment analysts have rated the stock with a hold rating, eighteen have assigned a buy rating and two have given a strong buy rating to the company. According to MarketBeat.com, the company has a consensus rating of “Moderate Buy” and an average price target of $615.53.

Check Out Our Latest Research Report on UNH

UnitedHealth Group Profile

(Free Report)

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.

Further Reading

Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Incorporated (NYSE:UNH – Free Report).